- ISIN
- US4330001060
- CUSIP
- 433000106
- Sector
- Healthcare
- IPO Date
- Sep 13, 2019
Highlights
- Market Cap
- $6.19B
- Enterprise Value
- $7.11B
- EPS (TTM)
- -$0.05
- Total Revenue (TTM)
- $2.37B
- Gross Profit (TTM)
- $1.70B
- EBITDA (TTM)
- $16.04M
- Year Range
- $13.74 - $65.59
- Target Price
- $26.20
- ROA (TTM)
- -0.58%
- ROE (TTM)
- -2.97%
- Avg. Volume (1M)
- 15M
- Avg. Volume Value (1M)
- $470.49M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
HIMS Performance Chart
Hims & Hers Health, Inc. (HIMS) is down 14.5% since the beginning of the year. At $28 per share, HIMS is trading 57.7% below its 52-week high of $66. Investors who bought $1,000 worth of HIMS shares 5 years ago would now be looking at an investment worth $3,510.
Loading charts...
Compare this symbol against anything
Returns By Period
Hims & Hers Health, Inc. (HIMS) has returned -14.47% so far this year and -55.60% over the past 12 months.
Hims & Hers Health, Inc.
- 1D
- 2.70%
- 1M
- -24.54%
- 6M
- 2.51%
- YTD
- -14.47%
- 1Y
- -55.60%
- 3Y*
- 46.90%
- 5Y*
- 28.55%
- 10Y*
- —
- ALL TIME*
- 16.38%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
HIMS Monthly Returns History
Based on dividend-adjusted daily data since Sep 13, 2019, HIMS's average daily return is +0.18%, while the average monthly return is +4.00%. At this rate, an investment would double in approximately 1.5 years.
Historically, 51% of months were positive and 49% were negative. The best month was Nov 2024 with a return of +71.1%, while the worst month was Feb 2026 at -46.4%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.
On a daily basis, HIMS closed higher 47% of trading days. The best single day was Mar 9, 2026 with a return of +40.8%, while the worst single day was Jun 23, 2025 at -34.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -16.57% | -46.40% | 42.98% | 30.88% | -3.75% | 32.58% | -19.90% | -14.47% | |||||
| 2025 | 54.18% | 20.95% | -34.46% | 12.01% | 70.88% | -11.86% | 32.76% | -36.01% | 33.93% | -19.85% | -12.54% | -18.34% | 34.28% |
| 2024 | -3.60% | 51.98% | 18.63% | -19.00% | 54.99% | 3.96% | 5.20% | -30.65% | 25.05% | 2.23% | 71.11% | -24.95% | 171.69% |
| 2023 | 29.17% | 36.11% | -11.98% | 16.83% | -22.86% | 5.15% | -4.57% | -25.20% | -6.26% | -4.93% | 48.66% | 0.11% | 38.85% |
| 2022 | -25.50% | 6.97% | 2.11% | -21.01% | -4.04% | 12.13% | 36.64% | 2.75% | -12.26% | -18.64% | 36.34% | 3.55% | -2.14% |
| 2021 | 30.07% | -23.28% | -9.20% | -6.42% | 16.40% | -24.43% | -27.36% | -0.38% | -4.31% | 3.45% | -16.03% | 0.00% | -55.14% |
Benchmark Metrics
Hims & Hers Health, Inc. has an annualized alpha of 32.53%, beta of 1.10, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since September 13, 2019.
- This stock captured 126.91% of S&P 500 Index gains and 118.44% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 32.53%
- Beta
- 1.10
- R²
- 0.08
- Upside Capture
- 126.91%
- Downside Capture
- 118.44%
Return for Risk
Risk / Return Rank
HIMS ranks 16 for risk / return — above 16% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HIMS | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.05 | ||
| Sortino ratioReturn per unit of downside risk | -2.75 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.25 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | 2.00 | -2.76 |
| Martin ratioReturn relative to average drawdown | -1.19 | 8.49 | -9.68 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Hims & Hers Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Hims & Hers Health, Inc. was 87.29%, occurring on May 11, 2022. Recovery took 528 trading sessions.
The current Hims & Hers Health, Inc. drawdown is 59.60%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-87.29%May 2022 | 1y 3mo | 2y 1mo | 3y 4moFeb 2021 - Jun 2024 | Bear market2022 |
-78.88%Feb 2026 | 1y 7d | — | 1y 5moFeb 2025 - now | — |
-44.94%Sep 2024 | 2mo 18d | 2mo 6d | 4mo 24dJun 2024 - Nov 2024 | — |
-30.70%Nov 2024 | 3d | 10d | 13dNov 2024 - Nov 2024 | — |
-29.36%Dec 2024 | 22d | 1mo 1d | 1mo 23dDec 2024 - Jan 2025 | — |
Drawdown Indicators
| HIMS | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.29% | -56.78% | -30.51% |
Max Drawdown (1Y)Largest decline over 1 year | -77.08% | -9.10% | -67.98% |
Max Drawdown (3Y)Largest decline over 3 years | -78.88% | -18.90% | -59.98% |
Max Drawdown (5Y)Largest decline over 5 years | -78.88% | -25.43% | -53.45% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -59.60% | -1.58% | -58.02% |
Average DrawdownAverage peak-to-trough decline | -43.40% | -10.70% | -32.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 50.87% | 2.14% | +48.73% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Hims & Hers Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Hims & Hers Health, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for HIMS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HIMS has a P/S ratio of 2.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for HIMS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HIMS has a P/B value of 14.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with HIMS
Add Hims & Hers Health, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with HIMS